Company intelligence / Profile preview

CMX Research

Oakville, Ontario, Canadacmxres.com ↗

Ownership: Private
Employees: ~7
Development stage: Other

Overview

CMX Research is a full-service Canadian CRO with over 32 years of experience and more than 425 completed Phase I–IV clinical trials. The company specializes in urology but covers multiple therapeutic areas and medical devices. It offers comprehensive project management from study design to post-marketing surveillance for pharmaceutical and biotech clients globally

Therapeutic areas: Men's HealthOncologyPulmonologyEndocrinologyImmunologyDermatologyCardiovascular
Modalities: Small moleculeBiologicMedical device
Industry: Contract Research Organization

Partnerships

UROsphere SAS – partnership for integrated preclinical to Phase IV urology research services between Canada and France

Beyond the preview

Go deeper on CMX Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CMX Research.

Explore the full profile